Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

Presentation AHA 2024

Randomized Comparison of Left Atrial Appendage Closure with Oral Anticoagulation after Catheter Ablation for Atrial Fibrillation

Presenter: Oussama M. Wazni

November 16, 2024

Presentation EACTS 2024

Streamlining Transcatheter Mitral Valve Replacement Screening

Presenter: Martin Beyer

October 10, 2024

Presentation ESC 2024

Optical coherence tomography-guided coronary intervention in patients with complex lesions: The OCCUPI Randomized Clinical Trial

Presenter: Byeong-Keuk Kim

September 02, 2024

Presentation ESC 2024

INFINITY-SWEDEHEART: Percutaneous coronary intervention with a Bioadaptor compared to a contemporary Drug-eluting Stent (DES) in a large broad clinical population

Presenter: David Erlinge

September 02, 2024

Presentation ESC 2024

DCB with rescue stenting versus intended stenting for de novo CAD: a multicenter, non-inferiority trial

Presenter: Ling Tao

September 02, 2024

Presentation ESC 2024

NOTION-3: PCI in patients undergoing transcatheter aortic valve implantation

Presenter: Jacob Lønborg

August 31, 2024

Presentation ESC 2024

Multicentric randomized evaluation of a Tricuspid valve Percutaneous Repair System (T-TEER) in the treatment of severe Tricuspid Regurgitation TRI.Fr

Presenter: Erwan Donal

August 31, 2024

Presentation EuroPCR 2024

One-month DAPT followed by 5-month Ti - cagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II

Presenter: Ling Tao

May 15, 2024

Presentation EuroPCR 2024

Is coronary artery bypass surgery cost-effective compared with contemporary PCI? A FAME 3 analysis

Presenter: Frederik Zimmermann

May 15, 2024

Presentation EuroPCR 2024

Methodological Insight: REC-CAGEFREE II Trial

Presenter: Robert Byrne

May 14, 2024

Presentation EuroPCR 2024

Impact of valve type and anaesthesia strategy for TAVI – 5-year results of the SOLVE-TAVI trial

Presenter: Hans-Josef Feistritzer

May 14, 2024

$Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)$

Presentation ACC 2024

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Presenter: Rasha K. Al-Lamee

April 08, 2024

Presentation ACC 2024

PREVENT: Preventive PCI versus Medical Therapy Alone for Treatment of Vulnerable Atherosclerotic Coronary Plaques

Presenter: Seung-Jung Park

April 07, 2024

Presentation ACC 2024

Percutaneous Transvalvular Micro axial Flow Pump in Infarct Related Cardiogenic Shock

Presenter: Jacob Eifer Møller

April 07, 2024

Presentation Miami Valves 2024

Contemporary management of AMI Shock in the Cath Lab – Evidence based Clinical Case?

Presenter: Carlos D. Davila

February 03, 2024

Presentation Miami Valves 2024

Catheter Based Treatment of Structural Heart Disease: Year in Review

Presenter: Eduardo de Marchena

February 01, 2024

Presentation Cardiovascular Interventions 2023

Shouldn’t Radiation Safety in the Cath Lab Be Our Top Priority?

Presenter: David G. Rizik

November 10, 2023

Presentation Complex Coronary Cases 2023

Enhancing Patient Experience in a High-Volume Cath Lab

Presenter: Jeannie Banton

June 16, 2023

Presentation Complex Coronary Cases 2023

Radiation Physics & Safety within the Cath Lab

Presenter: Jacob Kamen

June 14, 2023

Advertisement

Randomized Comparison of Left Atrial Appendage Closure with Oral Anticoagulation after Catheter Ablation for Atrial Fibrillation

Streamlining Transcatheter Mitral Valve Replacement Screening

Optical coherence tomography-guided coronary intervention in patients with complex lesions: The OCCUPI Randomized Clinical Trial

INFINITY-SWEDEHEART: Percutaneous coronary intervention with a Bioadaptor compared to a contemporary Drug-eluting Stent (DES) in a large broad clinical population

DCB with rescue stenting versus intended stenting for de novo CAD: a multicenter, non-inferiority trial

NOTION-3: PCI in patients undergoing transcatheter aortic valve implantation

Multicentric randomized evaluation of a Tricuspid valve Percutaneous Repair System (T-TEER) in the treatment of severe Tricuspid Regurgitation TRI.Fr

One-month DAPT followed by 5-month Ti - cagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II

Is coronary artery bypass surgery cost-effective compared with contemporary PCI? A FAME 3 analysis

Methodological Insight: REC-CAGEFREE II Trial

Impact of valve type and anaesthesia strategy for TAVI – 5-year results of the SOLVE-TAVI trial

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

PREVENT: Preventive PCI versus Medical Therapy Alone for Treatment of Vulnerable Atherosclerotic Coronary Plaques

Percutaneous Transvalvular Micro axial Flow Pump in Infarct Related Cardiogenic Shock

Contemporary management of AMI Shock in the Cath Lab – Evidence based Clinical Case?

Catheter Based Treatment of Structural Heart Disease: Year in Review

Shouldn’t Radiation Safety in the Cath Lab Be Our Top Priority?

Enhancing Patient Experience in a High-Volume Cath Lab

Radiation Physics & Safety within the Cath Lab

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content